Personalized peptide vaccination for cervical cancer patients who have received prior platinum-based chemotherapy

A feasibility study was performed to evaluate the immunological efficacy and safety of a personalized peptide vaccine (PPV) for cervical cancer patients who have received platinum-based chemotherapy. A total of 24 patients with standard chemotherapy-resistant cervical cancer, including 18 recurrent...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawano, Kouichiro, Tsuda, Naotake, Waki, Kayoko, Matsueda, Satoko, Hata, Yoshiro, Ushijima, Kimio, Itoh, Kyogo, Yamada, Akira, Kamura, Toshiharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582979/
https://www.ncbi.nlm.nih.gov/pubmed/26122553
http://dx.doi.org/10.1111/cas.12729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582979/
https://www.ncbi.nlm.nih.gov/pubmed/26122553
http://dx.doi.org/10.1111/cas.12729

Ejemplares similares